Multifaceted metabolic role of infections in the tumor microenvironment

Hanna F Willenbockel1, Birte Dowerg1, Thekla Cordes1

  • 1Department of Bioinformatics and Biochemistry, Braunschweig Integrated Centre of Systems Biology (BRICS), Technische Universität Braunschweig, Braunschweig, Germany; Research Group Cellular Metabolism in Infection, Helmholtz Centre for Infection Research, Braunschweig, Germany.

PubMed

Insights

Microorganisms like bacteria and viruses significantly impact tumor growth by altering the tumor microenvironment (TME). Engineered microbes offer promising new strategies for cancer detection and treatment, focusing on metabolic reprogramming.

Area of Science:

  • Oncology
  • Microbiology
  • Immunology

Background:

  • The influence of microorganisms on tumor development is a recognized phenomenon.
  • Recent research highlights the expanded role of the tumor microenvironment (TME) in hosting microbial communities.
  • Infections can reprogram tumor cell metabolism and modulate immune responses, affecting cancer progression.

Purpose of the Study:

  • To review recent findings on how bacteria and viruses mechanistically affect the TME.
  • To explore therapeutic strategies for cancer treatment that leverage microbial interactions and metabolic alterations.
  • To discuss the potential of engineered bacteria and viruses in novel cancer therapies.

Main Methods:

  • Literature review of recent discoveries on microbial impact on TME.
  • Analysis of mechanisms underlying microbial influence on tumor cell metabolism and immunity.
  • Examination of current and emerging cancer therapy strategies involving microbes.

Main Results:

  • Microbial infections induce significant metabolic reprogramming within the TME.
  • These infections modulate immune responses, with dual effects on tumor proliferation and metastasis.
  • The inherent ability of microbes to alter the TME is being harnessed for cancer detection and treatment.

Conclusions:

  • Bacteria and viruses play a complex role in cancer, influencing tumor growth and metastasis.
  • Targeting microbial-induced metabolic alterations presents a promising avenue for cancer therapy.
  • Engineered bacteria and viruses represent a novel frontier for developing effective cancer treatments.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K